Slingshot members are tracking this corporate initiative:
HTG Molecular (HTGM) Agrees to Develop Companion Diagnostic Tests for Merck KGaA's (MKGAY) Cancer Candidates
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Oct 11, 2016 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Don’t see a project related to the strategic initiative you care about?
Related Keywords Companion Diagnostic Tests, Cancer Candidates, Edgeseq Dlbcl Cell Of Origin Assay, M7583, Bruton's Tyrosine Kinase, Development Agreement